<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An alternative transcript variant of SLC39A14, caused by pre-<z:chebi fb="2" ids="33699">mRNA</z:chebi> splicing, was recently suggested as a biomarker for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>In our study, we have validated the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific splicing pattern of the mutually exclusive exons 4A and 4B in altogether 244 colorectal tissue samples </plain></SENT>
<SENT sid="2" pm="."><plain>Exon-specific quantitative RT-PCR analyses across 136 Stage I-IV <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples and 44 <z:mpath ids='MPATH_458'>normal</z:mpath> colonic mucosa samples showed complete <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specificity, as well as 94% sensitivity of SLC39A14-exon4B relative to SLC39A14-exon4A expression </plain></SENT>
<SENT sid="3" pm="."><plain>However, across 20 samples from a range of healthy tissues, 18 expressed the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> variant </plain></SENT>
<SENT sid="4" pm="."><plain>This was true also for ten benign lymph nodes, demonstrating that the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specificity is mainly confined to the colon and rectum </plain></SENT>
<SENT sid="5" pm="."><plain>Hence, clinical use of SLC39A14-exon4B as a detection marker for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> other than in samples taken from the bowel wall is diminished </plain></SENT>
<SENT sid="6" pm="."><plain>Prognostic value by detection of <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">metastasis to lymph nodes</z:e> is also abated, elucidating an important pitfall to biomarker discovery </plain></SENT>
<SENT sid="7" pm="."><plain>However, analyses of ten nondysplastic biopsies from patients with active <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> showed negative results in seven samples and only weakly positive results in three samples, suggesting value of SLC39A14-exon4B as a marker to distinguish <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> from other pathologic conditions of the colon </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, the SLC39A14-exon4B transcript variant is a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> biomarker with high sensitivity and organ-confined specificity </plain></SENT>
<SENT sid="9" pm="."><plain>Further use of the transcript and its encoded protein isoform should be explored in an organ-confined context </plain></SENT>
</text></document>